Evaluation of novel microtubules interfering agents myoseverin, tubulyzine and E2GG in primary cultures of rat hepatocytes

General Physiology and Biophysics

Volumn 26, Issue 3, 2007, Pages 173-180

  Dvořák, Zdeněk ^a   Modriansky M ^a   Vrba, J ^a   Ulrichova J ^a   Krystof V ^a   Styskala J ^a   Pavek P ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cellular signaling; Cytochrome P450; Microtubule; Myoseverin; Tubulin polymerization; Tubulyzine

Indexed keywords

2 (4 METHOXYBENZYLAMINE) 4,6 DICHLORO [1,3,5]TRIAZINE; 2 CYCLOHEXYLAMINO 4 (4 METHOXYBENZYLAMINO) 6 CHLORO [1,3,5]TRIAZINE; COLCHICINE; CYTOCHROME P450 1A1; CYTOSTATIC AGENT; DIOXIN; E 2GG; MESSENGER RNA; MYOSEVERIN; NOCODAZOLE; TRIAZINE DERIVATIVE; TUBULIN; TUBULYZINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; IC 50; IMMUNOHISTOCHEMISTRY; LIVER CELL; MICROTUBULE ASSEMBLY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; MICROTUBULES; PROTEIN BINDING; PURINES; RATS; TRIAZINES;

RATTUS;

EID: 36549016681     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Andreu J. M., Gorbunoff M.J., Lee J. C., Timasheff S. N. (1984): Interaction of tubulin with bifunctional colchicine analogues: an equilibrium study. Biochemistry 23, 1742-1752
2. Barbier P., Gregoire C., Devred F., Sarrazin M., Peyrot V. (2001): In vitro effect of cryptophycin 52 on microtubule assembly and tubulin: molecular modeling of the mechanism of action of a new antimitotic drug. Biochemistry 40, 13510-13519
3. Chang Y. T., Wignall S. M., Rosania G. R., Gray N. S., Hanson S. R., Su A. I., Merlie J. Jr., Moon H. S., Sangankar S. B., Perez O., Heald R., Schultz P. G. (2001): Synthesis and biological evaluation of myoseverin derivatives: microtubule assembly inhibitors. J. Med. Chem. 44, 4497-4500
4. Dvořák Z., Ulrichová J., Pichard-Garcia L., Modrianský M., Maurel P. (2002): Comparative effect of colchicine and colchiceine on cytotoxicity and CYP gene expression in primary human hepatocytes. Toxicol. in Vitro 16, 219-227
5. Dvořák Z., Maurel P., Ulrichová J., Modrianský M. (2004): Microtubule disarray in primary cultures of human hepatocytes inhibits transcriptional activity of the glucocorticoid receptor via activation of c-jun N-terminal kinase. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 148, 135-139
6. Dvorak Z., Modriansky M., Ulrichova J., Maurel P., Vilarem M. J., Pascussi J. M. (2005a): Disruption of microtubules leads to glucocorticoid receptor degradation in HeLa cell line. Cell. Signal. 17, 187-196
7. Dvorak Z., Ulrichova J., Modriansky M. (2005b): Role of microtubules network in CYP genes expression. Curr. Drug. Metab. 6, 545-552
8. Dvořák Z., Vrzal R., Maurel P, Ulrichová J. (2006a): Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-κB in HeLa cells. Chem. Biol. Interact. 159, 117-128
9. Dvořák Z., Vrzal R., Ulrichová J., Pascussi J. M., Maurel P., Modrianský M. (2006b): Involvement of cytoskeleton in AhR-dependent CYP1A1 expression. Curr. Drug Metab. 7, 301-303
10. Galigniana M. D., Scruggs J. L., Herrington J., Welsh M. J., Carter-Su C., Housley P. R., Pratt W. B. (1998): Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol. Endocrinol. 12, 1903-1913
11. 2 in cardiac myocytes. Biochem. Biophys. Res. Commun. 307, 416-421
12. Kim Y. J., Sackett D. L., Schapira M., Walsh D. P., Min J., Pannell L. K., Chang Y. T. (2006): Identification of 12Cisβ on tubulin as the binding site of tubulyzine. Bioorg. Med. Chem. 14, 1169-1175
13. Kryštof V., Moravcová D., Paprskářová M., Barbier P., Peyrot V., Hlobilková A., Havlíček L., Strnad M. (2006): Synthesis and biological activity of 8-azapurine and pyrazolo[4,3-d]pyrimidine analogues of myoseverin. Eur. J. Med. Chem. 41, 1405-1411
14. Lee J. C., Frigon R. P., Timasheff S. N. (1973): The chemical characterization of calf brain microtubule protein subunits. J. Biol. Chem. 248, 7253-7262
15. Modrianský M., Dvotřák Z. (2005): Microtubule disruptors and their interaction with biotransformation enzymes. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149, 213-215
16. Moldeus P., Hogberg J., Orrenius S. (1978): Isolation and use of liver cells. Methods Enzymol. 52, 60-71
17. Moon H. S., Jacobson E. M., Khersonsky S. M., Luzung M. R., Walsh D. P., Xiong W., Lee J. W., Parikh P. B., Lam J. C., Kang T. W., Rosania G. R., Schier A. F., Chang Y. T. (2002): A novel microtubule destabilizing entity from orthogonal synthesis of triazine library and zebrafish embryo screening. J. Am. Chem. Soc. 124, 11608-11609
18. Pascussi J. M., Dvorak Z., Gerbal-Chaloin S., Assenat E., Maurel P., Vilarem M. J. (2003): Pathophysiologica] factors affecting CAR gene expression. Drug Metab. Rev. 35, 255-268
19. Pascussi J. M., Dvorak Z., Gerbal-Chaloin S., Assenat E., Drocourt L., Maurel P., Vilarem M. J. (2004): Regulation of xenobiotic detoxification by PXR, CAR, GR, VDR and SHP receptors: Consequences in physiology. In: Transcription Factors (Ed. K. Starke), pp. 409-435, Springer-Verlag
20. Perez O. D., Chang Y. T., Rosania G., Sutherlin D., Schultz P. G. (2002): Inhibition and reversal of myogenic differentiation by purine-based microtubule assembly inhibitors. Chem. Biol. 9, 475-483
21. Rosania G. R., Chang Y. T., Perez O., Sutherlin D., Dong H., Lockhart D. J., Schultz P. G. (2000): Myoseverin, a microtubule-binding molecule with novel cellular effects. Nat. Biotechnol. 18, 304-308
22. Rosette C., Karin M. (1995): Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-κB. J. Cell. Biol. 128, 1111-1119
23. Wang T. H., Wang H. S., Ichijo H., Giannakakou P., Foster J. S., Fojo T., Wimalasena J. (1998): Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273, 4928-4936